Oct. 13 at 5:43 PM
$ZTS poised for a comeback with Lenivia — a game-changer for canine OA? 🐕💉
Zoetis’ Lenivia, targeting nerve growth factor, has a positive opinion from the EU CVMP and could hit the market in 2026, offering a novel option for OA pain with quarterly dosing. This could bolster ZTS' market presence in the EU and beyond.
Discover the potential impact on ZTS here 👉 https://www.zacks.com/stock/news/2767701/zoetis-gains-cvmp-backing-for-lenivia-eyes-eu-approval-in-dog-oa-pain?cid=sm-stocktwits-2-2767701-body-15785&ADID=SYND_STOCKTWITS_TWEET_2_2767701_BODY_15785